Mardia Samyoung Capillary Tubes Company Ltd vs Riddhi Siddhi Gluco Biols Ltd Stock Comparison
Mardia Samyoung Capillary Tubes Company Ltd vs Riddhi Siddhi Gluco Biols Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Mardia Samyoung Capillary Tubes Company Ltd is ₹ 45.25 as of 23 Oct 15:30
. The P/E Ratio of Mardia Samyoung Capillary Tubes Company Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Riddhi Siddhi Gluco Biols Ltd changed from 110.7 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Riddhi Siddhi Gluco Biols Ltd changed from ₹ 176.46 crore on March 2021 to ₹ 294.17 crore on March 2026 . This represents a CAGR of 8.89% over 6 years The revenue of Mardia Samyoung Capillary Tubes Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Riddhi Siddhi Gluco Biols Ltd for the Jun '26 is ₹ 106.86 crore as compare to the Mar '26 revenue of ₹ 20.06 crore. This represent the growth of 432.7% The ebitda of Mardia Samyoung Capillary Tubes Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Riddhi Siddhi Gluco Biols Ltd for the Jun '26 is ₹ 13.51 crore as compare to the Mar '26 ebitda of ₹ -24.85 crore. This represent the decline of -154% The net profit of Mardia Samyoung Capillary Tubes Company Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The net profit of Riddhi Siddhi Gluco Biols Ltd changed from ₹ 23.89 crore to ₹ 3.01 crore over 9 quarters. This represents a CAGR of -60.18%
The Dividend Payout of Mardia Samyoung Capillary Tubes Company Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Riddhi Siddhi Gluco Biols Ltd changed from 0.99 % on March 2022 to 3.8 % on March 2026 . This represents a CAGR of 30.87% over 5 years .
About Mardia Samyoung Capillary Tubes Company Ltd
Mardia Samyoung Capillary Tubes Company Limited, a Joint Venture between Mardia Group Companies i.e., Mardia Extrusions & Mardia Tubes and Samyoung Jung Kwan Company of South Korea was incorporated in October, 1992.
Initially, the Company was engaged in manufacture of capillary and thin-walled pipes and tubes made from brass, stainless steel, copper and other copper alloys.
The foreign collaborator holds 25% stake in the Company.
At present, the Company is engaged in manufacture of non-ferrous metals.
The foreign collaborator Samyoung, S.Korea has agreed to buy 6000 tpa of the finished products of the company apart from providing financial and technical collaboration.
The company's manufacturing facility with an installed capacity of 1800 tpa is located in Silvassa.
About Riddhi Siddhi Gluco Biols Ltd
Riddhi Siddhi Gluco Boils Limited was formerly incorporated as Riddhi Siddhi Starch & Chemicals Private Limited, as a Private Limited Company in July, 1990.
The company became a public limited company in February, 1992 and its name was changed to Riddhi Siddhi Starch & Chemicals Limited in April, 1992 and was again changed to Riddhi Siddhi Gluco Boils Limited in March, 2002.
The Company is engaged in the business of generation and selling power through windmills and in business of trading in agriculture and metal commodity items.
The Company had sold its Corn Processing Business during FY 2011-12, and invested the sale proceeds realized into various treasury instruments to optimize the return on surplus / idle funds.
The company came out with a public issue in Nov.'93 to part-finance a project to set up an unit to manufacture starch and its by-products in Junapadhar (Ahmedabad district), Gujarat.
FAQs for the comparison of Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd
Which company has a larger market capitalization, Mardia Samyoung Capillary Tubes Company Ltd or Riddhi Siddhi Gluco Biols Ltd?
Market cap of Mardia Samyoung Capillary Tubes Company Ltd is 359 Cr while Market cap of Riddhi Siddhi Gluco Biols Ltd is 456 Cr
What are the key factors driving the stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd?
The stock performance of Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd?
As of October 25, 2026, the Mardia Samyoung Capillary Tubes Company Ltd stock price is INR ₹45.25. On the other hand, Riddhi Siddhi Gluco Biols Ltd stock price is INR ₹640.35.
How do dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd compare?
To compare the dividend payouts of Mardia Samyoung Capillary Tubes Company Ltd and Riddhi Siddhi Gluco Biols Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.